Cite
MLA Citation
A. Eremeeva et al.. “AB0034 Pharmacokinetics and Safety of BCD-057, Adalimumab Biosimilar Candidate, Compared To Humira in Healthy Volunteers (Results of Phase I Clinical Study).” Annals of the rheumatic diseases, vol. 75, n.d., p. 908. http://access.bl.uk/ark:/81055/vdc_100135127557.0x000054